Effects of Different Intensities of Bilateral-transcranial Direct Current Stimulation in Healthy Individuals

NCT ID: NCT05929014

Last Updated: 2025-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-24

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will investigate the effects of 1 mA, 1.5 mA, and 2 mA of bilateral- tDCS on cortical activity and motor learning in healthy individuals

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Transcranial direct current stimulation (tDCS) is one of the non-invasive brain stimulation (NIBS) techniques. It delivers weak direct current through the scalp via two electrodes. tDCS has been shown to modulate cortical excitability in polarity-specific effects; anodal increases cortical excitability, while cathodal decreases it. tDCS can be applied in two distinct montages: unilateral (an active electrode is applied over the cerebral cortex, while a reference electrode is applied over the contralateral orbit) and bilateral-tDCS (applying two electrodes simultaneously over both cerebral hemispheres). Many tDCS studies have been used as an add-on therapy in stroke patients which aimed to enhance motor re-learning after stroke. Anodal tDCS has been used to enhance cortical excitability in the lesioned hemisphere while cathodal tDCS is used to decrease it in the non-lesioned hemisphere and thus to rebalance the interhemispheric inhibition (IHI). However, there were recent studies reporting the reverse effect of cathodal-tDCS on cortical excitability at high doses. However, the effects of bilateral-tDCS among different doses on cortical excitability and on motor performance are still controversial.

The present study will be investigated the effects of different intensities of bilateral-tDCS on cortical activity and functional outcomes in healthy individuals. A single session of different intensities of bilateral-tDCS (i.e., 1 mA, 1.5 mA, 2 mA vs. sham) will be combined with serial reaction time task (SRTT) in healthy individuals. Cortical activity (i.e., brain symmetry index (BSI)) will be measured as a primary outcome. The reaction time of serial reaction time task will be served as the secondary outcome. Cortical activity will be evaluated before and after the intervention, while reaction time will be evaluated before, during, and after the intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

The participants who will participate in the study will be randomly received 1 mA or 1.5 mA or 2 mA or sham with the washout period for at least 2 weeks.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active bilateral-tDCS

Participants will be received different intensities which are 1 mA, 1.5 mA and 2 mA for 20 minutes during performed serial reaction time task. The tDCS will be set with bilateral montage which applied anodal electrode over left hemisphere and cathodal electrode over right hemisphere.

Group Type ACTIVE_COMPARATOR

Bilateral-Transcranial direct current stimulation (bilateral-tDCS)

Intervention Type DEVICE

The tDCS is non-invasive brain stimulation technique applied over the participant's scalp using a reference to the International 10-20 electrode Placement System for EEG electrode placement. The cathodal and anodal electrodes will be applied over the right and left primary motor areas, respectively.

Sham bilateral-tDCS

Participants will be received sham of bilateral tDCS during performed serial reaction time task.

Group Type SHAM_COMPARATOR

Sham bilateral-tDCS

Intervention Type DEVICE

Sham bilateral-tDCS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bilateral-Transcranial direct current stimulation (bilateral-tDCS)

The tDCS is non-invasive brain stimulation technique applied over the participant's scalp using a reference to the International 10-20 electrode Placement System for EEG electrode placement. The cathodal and anodal electrodes will be applied over the right and left primary motor areas, respectively.

Intervention Type DEVICE

Sham bilateral-tDCS

Sham bilateral-tDCS

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MINDD STIM; Ybrain Inc., Korea

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Age 18-29 years old
* 2\. Righ-hand dominant according to the Edinburgh handedness inventory
* 3\. No injury to both upper and lower limb for the past 6 months

Exclusion Criteria

* 1\. Presence of any neurological disorders
* 2\. Presence of metal implantation, intracranial shunt, cochlear implantation, or cardiac pacemakers
* 3\. Presence of opened wound or infectious wound around scalp
* 4\. History of epilepsy or any neurological antecedent or unstable condition which can lead to seizure
* 5\. Body mass index (BMI) \> 30 kg/m2
* 6\. Received hormonal treatment and/or drugs that increase sleepiness and affect movement control
* 7\. Ischemic heart disease and peripheral vascular ischemia
* 8\. Last stage of kidney disease and liver disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

29 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wanalee Klomjai, PhD

Role: PRINCIPAL_INVESTIGATOR

Mahidol University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy, Mahidol University

Salaya, Nakonpathom, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MU-CIRB 2023/016.1601

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Non-Invasive Brain Stimulation
NCT04318522 UNKNOWN NA